MedPath

CERRX, INC.

CERRX, INC. logo
🇺🇸United States
Ownership
Private
Established
2008-01-01
Employees
1
Market Cap
-
Website
http://www.cerrx.com

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

Trial of Intravenous Fenretinide Emulsion for Patients With Relapsed/Refractory Peripheral T-cell Lymphomas

Phase 2
Conditions
Peripheral T-cell Lymphoma
Interventions
First Posted Date
2015-07-13
Last Posted Date
2019-07-23
Lead Sponsor
CerRx, Inc.
Target Recruit Count
140
Registration Number
NCT02495415
Locations
🇺🇸

Banner MD Anderson Cancer Center, Gilbert, Arizona, United States

🇺🇸

USC Norris Comprehensive Cancer Center, Los Angeles, California, United States

🇺🇸

University of California, Los Angeles, Los Angeles, California, United States

and more 8 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.